Aligned Genetics Inc (238120) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.058x

Based on the latest financial reports, Aligned Genetics Inc (238120) has a cash flow conversion efficiency ratio of -0.058x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-2.04 Billion ≈ $-1.38 Million USD) by net assets (₩35.50 Billion ≈ $24.05 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 238120 net asset quality index to measure how much of total assets are equity-financed.

Aligned Genetics Inc - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how Aligned Genetics Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 238120 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Aligned Genetics Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Aligned Genetics Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Tigers Realm Coal Ltd AU:TIG	-0.316x
Audacia SAS PA:ALAUD	-0.098x
Garden Stage Limited Ordinary Shares NASDAQ:GSIW	-0.172x
TOP Ships Inc. NASDAQ:TOPS	0.110x
U-Tech Co Ltd KQ:178780	-0.015x
Steel Hawk Berhad KLSE:0320	N/A
KC Feed Co. Ltd KQ:025880	0.125x
Harvard Bioscience Inc NASDAQ:HBIO	-0.066x

Annual Cash Flow Conversion Efficiency for Aligned Genetics Inc (2015–2024)

The table below shows the annual cash flow conversion efficiency of Aligned Genetics Inc from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see market value of Aligned Genetics Inc.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩35.49 Billion ≈ $24.05 Million	₩3.07 Billion ≈ $2.08 Million	0.086x	-5.07%
2023-12-31	₩31.31 Billion ≈ $21.22 Million	₩2.85 Billion ≈ $1.93 Million	0.091x	+18.10%
2022-12-31	₩28.85 Billion ≈ $19.55 Million	₩2.22 Billion ≈ $1.51 Million	0.077x	+1429.28%
2021-12-31	₩26.99 Billion ≈ $18.29 Million	₩135.97 Million ≈ $92.14K	0.005x	+203.10%
2020-12-31	₩21.46 Billion ≈ $14.55 Million	₩35.67 Million ≈ $24.17K	0.002x	-94.71%
2019-12-31	₩20.97 Billion ≈ $14.21 Million	₩659.29 Million ≈ $446.79K	0.031x	+137.58%
2018-12-31	₩20.89 Billion ≈ $14.16 Million	₩-1.75 Billion ≈ $-1.18 Million	-0.084x	-116.08%
2017-12-31	₩22.64 Billion ≈ $15.34 Million	₩-876.75 Million ≈ $-594.16K	-0.039x	+17.86%
2016-12-31	₩24.18 Billion ≈ $16.39 Million	₩-1.14 Billion ≈ $-772.65K	-0.047x	+18.73%
2015-12-31	₩6.06 Billion ≈ $4.11 Million	₩-351.72 Million ≈ $-238.36K	-0.058x	--

About Aligned Genetics Inc

KQ:238120 Korea Medical Devices

Market Cap

$27.72 Million

₩40.91 Billion KRW

Market Cap Rank

#23974 Global

#1647 in Korea

Share Price

₩2910.00

Change (1 day)

+1.75%

52-Week Range

₩2680.00 - ₩6050.00

All Time High

₩7875.00